HBOT Conversations:
Dr. Paul Harch & Strokes

Dr. Paul G. Harch, M.D. has used hyperbaric oxygen therapy to treat more than 100 different conditions, including stroke, dementia, autism, and traumatic brain injury. His goal is to help his patients get their lives back using hyperbaric oxygen therapy.

He is the author of The Oxygen Revolution and is considered an International expert and pioneer in the field of Hyperbaric Oxygen Therapy (HBOT). His informative, and comprehensive guide on HBOT has helped countless souls better understand what HBOT is and how it directly affects the body at the genetic level.

This episode on strokes is the sixth in a nine episode series that will be released weekly with Dr. Harch.

Subscribe. Join the discussion. Share the hope.

Watch the Podcast

In episode 6 of 9, host Edward di Girolamo speaks with world renowned HBOT expert, Dr. Paul G. Harch about strokes. Dr. Harch explains that Hyperbaric Oxygen Therapy is hands-down the most effective therapy to treat the debilitating after-effects of a stroke.

But what exactly happens during a stroke and how can HBOT help?

We have more blood flow happening in the parts of the brain that are working hard to coordinate the movement of muscles, the formation of words, etc. Dr. Harch refers to this blood flow like the RPMs in a motor, the blood flow revs up and increases as we increase our movement & activity.  However, having a stroke causes a blockage or lowering of blood flow to the brain, which can cause “electrical silence” – when the cells get to a point at about 60% reduction in blood flow where they no longer have enough oxygen (and blood flow, sugar, and fat) to generate electrical signals. These cells do not die, they live in a state of idling.

Dr. Harch explains there was a strong misunderstanding among the medical community that brain cells were either alive or dead after a stroke or injury.  Over the years, HBOT has proven to the medical community that brain cells can just be in an idle/injured state and under the right conditions (like oxygen + pressure) they can be revived to function again.

Dr. Harch speaks in detail of two HBOT success stories of stroke patients getting significantly better even 10 years+ post-stroke —-

  1. A 60 year old woman who was 14 years post-stroke; paralyzed, drooling, can’t eat, no speech, totally dependent, and spending her days in a Geri Chair. Over the next 16 months they treated her periodically with Hyperbaric Oxygen Therapy and continue to do blood flow brain scans on her before and after the treatments. The deadest area of her brain immediately started to light up with blood flow after just the first treatment. She eventually reacquired her speech, stop drooling, and they were able to get her up moving with assisted ambulation.
  2. It was early 1990s and a Gentlemen called, Mr. H, who was 12 years post-stroke came into Dr. Harch’s clinic; completely mute with no ability to talk or communicate, unable to move at all; he just laid in bed all day. Eventually his wife had to put him in a nursing home, where he was referred to Hyperbaric Oxygen Therapy for the horrendous bed sore wounds he had developed.  They started treatment with HBOT and continued to treat him, even after the bed sores started healing.  The medical staff noticed that after about 18 HBOT treatment sessions he was now waving to the doctors and nurses as he was being wheeled through the doors on a stretcher.  So they keep treating him with HBOT…… 10 more treatments and he starts talking.  By flooding his body with oxygen under the pressure conditions of hyperbarics, for the first time in 12 years his brain started to wake up.

Moving away from topic of stroke, but still focusing on the power of Hyperbarics and success stories, di Girolamo tells Dr. Harch that he once said to Bill Duncan, “From what I understand of Hyperbaric Oxygen, the only thing it can’t do is bring back the dead.” And Bill responded with, “that’s not entirely true”. This opened the door for Dr. Harch to talk about a bizarre and fascinating Hyperbaric Oxygen Therapy success story from the 1980s. A diver was about 80 – 90 feet down in the Mississippi River with an airlift, as part of a mission to salvage a new tugboat that sunk. As the dive team was suctioning silt to loosen it up from the sunken boat, this diver’s helmet came off when he got sucked up against the bar of the dredging device. It took a long time for other divers to find him, and when they do bring him up he’s “dead as dead can be”. Without really knowing exactly why he’s in cardiac arrest, they immediately put him in a hyperbaric chamber in hopes that it would help stabilize him from any decompression sickness.  They put an oxygen mask on him and take him to six atmospheres of pressure (clinical chambers go to maximum 3) – that’s 165 feet of pressure!  He sparked up and came to life!  He had been in cardiac arrest for 25 minutes.  He went on to live a healthy life with a bright IQ. Later studies have involved guinea pigs, rats, and swine – some as much as 25 minutes after cardiac arrest and success with resuscitation after Hyperbaric Oxygen Therapy. So, yes there’s scientific proof that HBOT can even bring back the dead.

Dr. Harch stresses at the end of this HBOT Conversation that it’s never too late to get HBOT.  Obviously, the sooner the better; but it still works on patients many many years post-stroke. There are approximately 800,000 strokes per year in the United States — it’s a huge number.  And unfortunately only an extremely small amount of stroke victims receive Hyperbaric Oxygen Therapy. Dr. Harch classifies HBOT as “hope for the hopeless”.

If you or a loved one has recently experienced a stroke, we encourage you to better understand how Hyperbaric Oxygen Therapy can help wake up a post-stroke brain. We wish you the best as you find hope in HBOT.

 

Subscribe Now, It’s Free!

[contact-form-7 id="65934" title="Subscribe"]

Guest

Dr. Paul G. Harch

Dr. Paul G. Harch, MD

Dr. Paul G. Harch, M.D. is a clinician in emergency medicine and hyperbaric medicine who is the former director of the University Medical Center Hyperbaric Medicine Department and LSU Hyperbaric Medicine Fellowship. Currently, he is a Clinical Professor of Medicine in the Section of Emergency Medicine at LSU School of Medicine in New Orleans. He graduated from the Johns Hopkins University School of Medicine after graduating from the University of California at Irvine with magna cum laude/Phi Beta Kappa honors.

Dr. Harch initiated and continues to be a private practice that has resulted in the largest case experience in neurological hyperbaric medicine in the world. In this practice, he adapted the concepts of conventional hyperbaric oxygen therapy to wounds in the central nervous system, which spawned the subsequent academic and research practice. Harch HBOT is the best place to receive oxygen therapy treatments, and patients have traveled from more than 50 countries to be treated by Dr. Harch himself.

Harch HBOT – Hyperbaric Oxygen Therapy Clinic

5216 Lapalco Blvd.
Marrero, LA
504-309-4948
hbot@hbot.com
https://hbot.com/

 

Recent HBOT News

Clinical Trial – Transcranial Magnetic Stimulation and Hyperbaric Chamber for Women Fibromyalgia

Fibromyalgia syndrome (FMS) is a multisystem disease, characterized by generalized chronic
musculoskeletal pain. In addition, there is a lot of care for fatigue, sleep disorders,
morning stiffness, cognitive disorders, depression, anxiety and stress. Other common symptoms
are back pain, headaches, irritable bowel, balance problems and deterioration of physical
function in general. Patients with fibromyalgia (FM) often show pain at specific points that
are known as "tender spots or tender spots, with an increased sensitivity to painful stimuli"
(hyperalgesia) and a decreased pain threshold (allodynia). which can be evidenced in the
physical examination and in the absence of anomalies that justify in the biological or image
tests. These pain points to pressure, based on the most specific and specific criteria for
the diagnosis of the disease, traditionally based on the criteria of the American College of
Rheumatology (ACR), according to which, should be presented so minus 11 out of 18 painful
points to confirm it. Although the etiology remains unknown and unclear, its appearance is
attributed to a problem of central sensitization, that is, changes in central processing,
which causes an alteration of the mechanisms that regulate the sensation of pain, with
amplification of nociceptive input . and perpetuation of painful stimuli. Fibromyalgia is
becoming a common syndrome in the countries of Western Europe, with a prevalence in the
general population that ranges between 1-3%, and specifically in Spain, around 2.4%. In
addition, it has a higher incidence in women than men (73-95%), predominantly affecting women
between the ages of 40-50 years. About 3% of women with fibromyalgia are at an age when
menopause occurs, so not only do they experience the symptoms of both states but they even
exacerbate the syndrome with each other. On the other hand, and in relation to its
chronicity, the care of this type of patients involves large costs for society with a
significant consumption of health resources in the field of primary care, as well as the
costs of work absenteeism. For these reasons, it is considered an important problem with a
great impact on the health system, and therefore more and more studies are being developed
with the aim of better understanding the pathophysiology of this disease. The therapeutic
approach includes low cost and easy access measures, such as physical exercise (EF) programs
to improve the symptoms of FM. Physical exercise has positive effects directly on pain, joint
and muscle stiffness, generalized sensitivity and fatigue, among others, and secondarily on
cognitive disorders. Thus, the vast majority of studies focus on low-impact aerobic exercise,
performed between 60% and 70% of the maximum heart rate two to three times a week. However,
to date, there is no study that compares the effectiveness of physical exercise with other
innovative therapeutic actions, such as transcranial magnetic stimulation (TMS), the
hyperbaric chamber (HBOT), in parameters related to pain and quality of life. the life of
patients with fibromyalgia. The general objective is the effectiveness of transcranial
magnetic stimulation and the hyperbaric chamber in women with fibromyalgia. As specific
objectives we propose:

To assess the effect of HBOT, TMS and EF on quality of life in women with fibromyalgia.

– Object the effect of HBOT, TMS and EF in cortical functioning.

– Evaluate the effect of HBOT, TMS and EF on fatigue.

– Evaluate the effect of HBOT, TMS and EF on psychological aspects, such as depression and
anxiety.

– Evaluate the effect of HBOT, TMS and EF on the perception of pain and the number of
painful points.

– Evaluate the effect of HBOT, TMS and EF on the quality of sleep.

– Evaluate the effect of HBOT, TMS and EF on the quality of life.

– Evaluate the effect of HBOT, TMS and EF on the pain constructs.

– Determine the effect of HBOT, TMS and EF on plasma endorphin levels.